| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 2, 2003
From the Cardiac MR Research Group, Division of Imaging Sciences, King’s College (V.M., A.T., R.A., S.H., M.E.M., D.L.G.H., R.S.R.); the Department of Congenital Heart Disease, Guy’s Hospital (R.T., E.B., R.S.R.); and the Cardiothoracic Unit, Institute of Child Health and Great Ormond Street Hospital (A.T.), London, United Kingdom. * To whom correspondence should be addressed. E-mail: reza.razavi{at}kcl.ac.uk.
Background--Pulmonary vascular resistance (PVR) quantification is important in the treatment of children with pulmonary hypertension. The Fick principle, used to quantify pulmonary artery flow, may be a flawed technique. We describe a novel method of PVR quantification by the use of magnetic resonance (MR) flow data and invasive pressure measurements. Methods and Results--In 24 patients with either suspected pulmonary hypertension or congenital heart disease requiring preoperative assessment, PVR was calculated by the use of simultaneously acquired MR flow and invasive pressure measurements (condition 1). In 19 of the 24 patients, PVR was also calculated at 20 ppm nitric oxide +30% (condition 2) and at 20 ppm nitric oxide +100% oxygen (condition 3), with the use of the MR method. This method proved safe and feasible in all patients. In 15 of 19 patients, PVR calculated by Fick flow was compared with the MR method. At condition 1, Bland-Altman analysis revealed a bias of 2.3% (MR > Fick) and limits of agreement of 50.2% to -45.5%. At condition 2, there was poorer agreement (bias was 28%, and the limits of agreement were 151.3% to 95.2%). At condition 3, there was very poor agreement (bias was 54.2%, and the limits of agreement were 174.4% to -66.0%). Conclusions--We have demonstrated the feasibility of using simultaneous invasive pressure measurements and MR flow data to measure PVR in humans.
Revised on March 30, 2004
Accepted on April 2, 2004
Novel Method of Quantifying Pulmonary Vascular Resistance by Use of Simultaneous Invasive Pressure Monitoring and Phase-Contrast Magnetic Resonance Flow
Vivek Muthurangu BSc, MBChB, MRCPCH,
This article has been cited by other articles:
![]() |
A. Bell, P. Beerbaum, G. Greil, S. Hegde, A. M. Toschke, T. Schaeffter, and R. Razavi Noninvasive Assessment of Pulmonary Artery Flow and Resistance by Cardiac Magnetic Resonance in Congenital Heart Diseases With Unrestricted Left-to-Right Shunt J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Saikus and R. J. Lederman Interventional Cardiovascular Magnetic Resonance Imaging: A New Opportunity for Image-Guided Interventions J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1321 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Müller, P. H. Rehak, M. Puchinger, D. Wagner, W. Marte, and K.-H. Tscheliessnigg Measurement of cardiac output and pulmonary transit time for assessment of pulmonary vascular resistance in domestic piglets Exp Physiol, June 1, 2009; 94(6): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Crean Cardiovascular MR and CT in congenital heart disease Heart, December 1, 2007; 93(12): 1637 - 1647. [Full Text] [PDF] |
||||
![]() |
A. Vonk-Noordegraaf, J.-W. Lankhaar, M. J.W. Gotte, J. T. Marcus, P. E. Postmus, and N. Westerhof Magnetic resonance and nuclear imaging of the right ventricle in pulmonary arterial hypertension Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H29 - H34. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Muthurangu, A. M. Taylor, S. R. Hegde, R. Johnson, R. Tulloh, J. M. Simpson, S. Qureshi, E. Rosenthal, E. Baker, D. Anderson, et al. Cardiac Magnetic Resonance Imaging After Stage I Norwood Operation for Hypoplastic Left Heart Syndrome Circulation, November 22, 2005; 112(21): 3256 - 3263. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Alphonso, M. Baghai, P. Sundar, R. Tulloh, C. Austin, and D. Anderson Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Muthurangu, D. Atkinson, M. Sermesant, M. E. Miquel, S. Hegde, R. Johnson, R. Andriantsimiavona, A. M. Taylor, E. Baker, R. Tulloh, et al. Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1301 - H1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Muthurangu and R S Razavi The value of magnetic resonance guided cardiac catheterisation Heart, August 1, 2005; 91(8): 995 - 996. [Full Text] [PDF] |
||||
![]() |
T Kuehne, S Yilmaz, I Schulze-Neick, E Wellnhofer, P Ewert, E Nagel, and P Lange Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension Heart, August 1, 2005; 91(8): 1064 - 1069. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |